(S)-nicotine (CHEBI:17688)

ChEBI > Main

CHEBI:17688 - (S)-nicotine

Main

ChEBI Ontology

Automatic Xrefs

Reactions

Pathways

Models

ChEBI Name	(S)-nicotine

ChEBI ID	CHEBI:17688

ChEBI ASCII Name	(S)-nicotine

Definition	A 3-(1-methylpyrrolidin-2-yl)pyridine in which the chiral centre has S-configuration. The naturally occurring and most active enantiomer of nicotine, isolated from Nicotiana tabacum.

Stars	This entity has been manually annotated by the ChEBI Team.

Secondary ChEBI IDs	CHEBI:44268, CHEBI:14653, CHEBI:25536, CHEBI:7562

Supplier Information	ZINC000008214766

Download	Molfile XML SDF

more structures >>

Molfile

call loadScript javascripts\jsmol\core\package.js

call loadScript javascripts\jsmol\core\core.z.js -- required by ClazzNode

call loadScript javascripts\jsmol\J\awtjs2d\WebOutputChannel.js

Jmol JavaScript applet jmolApplet0_object__897105007723749__ initializing

getValue debug = null

getValue logLevel = null

getValue allowjavascript = null

AppletRegistry.checkIn(jmolApplet0_object__897105007723749__)

call loadScript javascripts\jsmol\core\corestate.z.js

viewerOptions:

{ "name":"jmolApplet0_object","applet":true,"documentBase":"https://www.ebi.ac.uk/chebi/searchId.do?chebiId=CHEBI:17688","platform":"J.awtjs2d.Platform","fullName":"jmolApplet0_object__897105007723749__","display":"jmolApplet0_canvas2d","signedApplet":"true","appletReadyCallback":"Jmol._readyCallback","statusListener":"[J.appletjs.Jmol.MyStatusListener object]","codeBase":"https://www.ebi.ac.uk/chebi/javascripts/jsmol/","syncId":"897105007723749","bgcolor":"#000" }

Jmol Version: 13.2.7 $Date: 2013-10-01 11:35:15 -0500 (Tue, 01 Oct 2013) $

java.vendor: j2s

java.version: 0.0

os.name: j2s

Access: ALL

memory: 0.0/0.0

processors available: 1

useCommandThread: false

appletId:jmolApplet0_object (signed)

starting HoverWatcher_1

getValue emulate = null

defaults = "Jmol"

getValue boxbgcolor = null

getValue bgcolor = #000

backgroundColor = "#000"

getValue ANIMFRAMECallback = null

getValue APPLETREADYCallback = Jmol._readyCallback

APPLETREADYCallback = "Jmol._readyCallback"

getValue ATOMMOVEDCallback = null

getValue CLICKCallback = null

getValue ECHOCallback = null

getValue ERRORCallback = null

getValue EVALCallback = null

getValue HOVERCallback = null

getValue LOADSTRUCTCallback = null

getValue MEASURECallback = null

getValue MESSAGECallback = null

getValue MINIMIZATIONCallback = null

getValue PICKCallback = null

getValue RESIZECallback = null

getValue SCRIPTCallback = null

getValue SYNCCallback = null

getValue STRUCTUREMODIFIEDCallback = null

getValue doTranslate = null

language=en_US

getValue popupMenu = null

getValue script = null

Jmol applet jmolApplet0_object__897105007723749__ ready

call loadScript javascripts\jsmol\core\corescript.z.js

call loadScript javascripts\jsmol\J\script\FileLoadThread.js

starting QueueThread0_2

script 1 started

starting HoverWatcher_3

starting HoverWatcher_4

The Resolver thinks Mol

NCT - Ideal conformer

Mrv1927 02132314453D

starting HoverWatcher_5

Time for openFile(NCT - Ideal conformer

Mrv1927 02132314453D

26 27 0 0 0 0 999 V2000

-0.6730 1.1480 -2.4250 N 0 0 0 0 0 0 0 0 0 0 0 0

-0.6330 0.8820 -1.1340 C 0 0 0 0 0 0 0 0 0 0 0 0

-0.0180 -0.2630 -0.6670 C 0 0 0 0 0 0 0 0 0 0 0 0

0.5510 -1.1420 -1.5760 C 0 0 0 0 0 0 0 0 0 0 0 0

0.4840 -0.8320 -2.9250 C 0 0 0 0 0 0 0 0 0 0 0 0

-0.1420 0.3350 -3.3170 C 0 0 0 0 0 0 0 0 0 0 0 0

0.6150 0.5860 1.5560 N 0 0 1 0 0 0 0 0 0 0 0 0

0.0280 -0.5560 0.8100 C 0 0 1 0 0 0 0 0 0 0 0 0

-1.4030 -0.6620 1.3920 C 0 0 2 0 0 0 0 0 0 0 0 0

-1.1930 -0.3360 2.8880 C 0 0 2 0 0 0 0 0 0 0 0 0

0.1280 0.4510 2.9460 C 0 0 1 0 0 0 0 0 0 0 0 0

2.0660 0.3650 1.5940 C 0 0 0 0 0 0 0 0 0 0 0 0

-1.0790 1.5720 -0.4330 H 0 0 0 0 0 0 0 0 0 0 0 0

1.0350 -2.0470 -1.2400 H 0 0 0 0 0 0 0 0 0 0 0 0

0.9170 -1.4930 -3.6610 H 0 0 0 0 0 0 0 0 0 0 0 0

-0.1980 0.5850 -4.3660 H 0 0 0 0 0 0 0 0 0 0 0 0

0.5900 -1.4700 1.0020 H 0 0 0 0 0 0 0 0 0 0 0 0

-1.7950 -1.6710 1.2680 H 0 0 0 0 0 0 0 0 0 0 0 0

-2.0630 0.0680 0.9260 H 0 0 0 0 0 0 0 0 0 0 0 0

-1.1110 -1.2550 3.4680 H 0 0 0 0 0 0 0 0 0 0 0 0

-2.0150 0.2750 3.2610 H 0 0 0 0 0 0 0 0 0 0 0 0

0.8590 -0.0920 3.5440 H 0 0 0 0 0 0 0 0 0 0 0 0

-0.0450 1.4380 3.3750 H 0 0 0 0 0 0 0 0 0 0 0 0

2.2700 -0.6600 1.9020 H 0 0 0 0 0 0 0 0 0 0 0 0

2.4860 0.5360 0.6020 H 0 0 0 0 0 0 0 0 0 0 0 0

2.5210 1.0550 2.3050 H 0 0 0 0 0 0 0 0 0 0 0 0

1 2 2 0 0 0 0

1 6 1 0 0 0 0

2 3 1 0 0 0 0

2 13 1 0 0 0 0

3 4 2 0 0 0 0

3 8 1 0 0 0 0

4 5 1 0 0 0 0

4 14 1 0 0 0 0

5 6 2 0 0 0 0

5 15 1 0 0 0 0

6 16 1 0 0 0 0

7 8 1 0 0 0 0

7 11 1 0 0 0 0

7 12 1 0 0 0 0

8 9 1 0 0 0 0

8 17 1 6 0 0 0

9 10 1 0 0 0 0

9 18 1 0 0 0 0

9 19 1 0 0 0 0

10 11 1 0 0 0 0

10 20 1 0 0 0 0

10 21 1 0 0 0 0

11 22 1 0 0 0 0

11 23 1 0 0 0 0

12 24 1 0 0 0 0

12 25 1 0 0 0 0

12 26 1 0 0 0 0

M END): 18 ms

reading 26 atoms

ModelSet: haveSymmetry:false haveUnitcells:false haveFractionalCoord:false

1 model in this collection. Use getProperty "modelInfo" or getProperty "auxiliaryInfo" to inspect them.

Default Van der Waals type for model set to Babel

26 atoms created

ModelSet: not autobonding; use forceAutobond=true to force automatic bond creation

Script completed

Jmol script terminated

Molfile expand

Wikipedia	License
Nicotine is a naturally produced alkaloid in the nightshade family of plants (most predominantly in tobacco and Duboisia hopwoodii) and is widely used recreationally as a stimulant and anxiolytic. As a pharmaceutical drug, it is used for smoking cessation to relieve withdrawal symptoms. Nicotine acts as a receptor agonist at most nicotinic acetylcholine receptors (nAChRs), except at two nicotinic receptor subunits (nAChRα9 and nAChRα10) where it acts as a receptor antagonist. Nicotine constitutes approximately 0.6–3.0% of the dry weight of tobacco. Nicotine is also present at ppb concentrations in edible plants in the family Solanaceae, including potatoes, tomatoes, and eggplants, though sources disagree on whether this has any biological significance to human consumers. It functions as an antiherbivore toxin; consequently, nicotine was widely used as an insecticide in the past, and neonicotinoids (structurally similar to nicotine), such as imidacloprid, are some of the most effective and widely used insecticides. Nicotine is highly addictive. Slow-release forms (gums and patches, when used correctly) can be less addictive and help in quitting. Animal research suggests that monoamine oxidase inhibitors present in tobacco smoke may enhance nicotine's addictive properties. An average cigarette yields about 2 mg of absorbed nicotine. The estimated lower dose limit for fatal outcomes is 500–1,000 mg of ingested nicotine for an adult (6.5–13 mg/kg). Nicotine addiction involves drug-reinforced behavior, compulsive use, and relapse following abstinence. Nicotine dependence involves tolerance, sensitization, physical dependence, and psychological dependence, which can cause distress. Nicotine withdrawal symptoms include depression, stress, anxiety, irritability, difficulty concentrating, and sleep disturbances. Mild nicotine withdrawal symptoms are measurable in unrestricted smokers, who experience normal moods only as their blood nicotine levels peak, with each cigarette. On quitting, withdrawal symptoms worsen sharply, then gradually improve to a normal state. Nicotine use as a tool for quitting smoking has a good safety history. Animal studies suggest that nicotine may adversely affect cognitive development in adolescence, but the relevance of these findings to human brain development is disputed. At low amounts, it has a mild analgesic effect. According to the International Agency for Research on Cancer, "nicotine is not generally considered to be a carcinogen". The Surgeon General of the United States indicates that evidence is inadequate to infer the presence or absence of a causal relationship between exposure to nicotine and risk for cancer. Nicotine has been shown to produce birth defects in humans and is considered a teratogen. The median lethal dose of nicotine in humans is unknown. High doses are known to cause nicotine poisoning, organ failure, and death through paralysis of respiratory muscles, though serious or fatal overdoses are rare.
Read full article at Wikipedia

Formula

C10H14N2

Net Charge

Average Mass

162.236

Monoisotopic Mass

162.11570

InChI

InChI=1S/C10H14N2/c1-12-7-3-5-10(12)9-4-2-6-11-8-9/h2,4,6,8,10H,3,5,7H2,1H3/t10-/m0/s1

InChIKey

SNICXCGAKADSCV-JTQLQIEISA-N

SMILES

[H][C@]1(CCCN1C)C1=CC=CN=C1

Metabolite of Species	Details
Nicotiana tabacum (NCBI:txid4097)	See: PubMed

Roles Classification
Chemical Role(s):	Bronsted base A molecular entity capable of accepting a hydron from a donor (Bronsted acid). (via organic amino compound )

Biological Role(s):	teratogenic agent A role played by a chemical compound in biological systems with adverse consequences in embryo developments, leading to birth defects, embryo death or altered development, growth retardation and functional defect. immunomodulator Biologically active substance whose activity affects or plays a role in the functioning of the immune system. mitogen A chemical substance that encourages a cell to commence cell division, triggering mitosis. plant metabolite Any eukaryotic metabolite produced during a metabolic reaction in plants, the kingdom that include flowering plants, conifers and other gymnosperms. xenobiotic A xenobiotic (Greek, xenos "foreign"; bios "life") is a compound that is foreign to a living organism. Principal xenobiotics include: drugs, carcinogens and various compounds that have been introduced into the environment by artificial means. neurotoxin A poison that interferes with the functions of the nervous system. nicotinic acetylcholine receptor agonist An agonist that selectively binds to and activates a nicotinic acetylcholine receptor. metabolite Any intermediate or product resulting from metabolism. The term 'metabolite' subsumes the classes commonly known as primary and secondary metabolites. (via alkaloid )

Application(s):	biomarker A substance used as an indicator of a biological state. immunomodulator Biologically active substance whose activity affects or plays a role in the functioning of the immune system. peripheral nervous system drug A drug that acts principally at one or more sites within the peripheral neuroeffector systems, the autonomic system, and motor nerve-skeletal system. psychotropic drug A loosely defined grouping of drugs that have effects on psychological function. anxiolytic drug Anxiolytic drugs are agents that alleviate anxiety, tension, and anxiety disorders, promote sedation, and have a calming effect without affecting clarity of consciousness or neurologic conditions. nicotinic acetylcholine receptor agonist An agonist that selectively binds to and activates a nicotinic acetylcholine receptor. phytogenic insecticide An insecticide compound naturally occurring in plants.

View more via ChEBI Ontology

ChEBI Ontology
Outgoing	(S)-nicotine (CHEBI:17688) has role anxiolytic drug (CHEBI:35474) (S)-nicotine (CHEBI:17688) has role biomarker (CHEBI:59163) (S)-nicotine (CHEBI:17688) has role immunomodulator (CHEBI:50846) (S)-nicotine (CHEBI:17688) has role mitogen (CHEBI:52290) (S)-nicotine (CHEBI:17688) has role neurotoxin (CHEBI:50910) (S)-nicotine (CHEBI:17688) has role nicotinic acetylcholine receptor agonist (CHEBI:47958) (S)-nicotine (CHEBI:17688) has role peripheral nervous system drug (CHEBI:49110) (S)-nicotine (CHEBI:17688) has role phytogenic insecticide (CHEBI:22917) (S)-nicotine (CHEBI:17688) has role plant metabolite (CHEBI:76924) (S)-nicotine (CHEBI:17688) has role psychotropic drug (CHEBI:35471) (S)-nicotine (CHEBI:17688) has role teratogenic agent (CHEBI:50905) (S)-nicotine (CHEBI:17688) has role xenobiotic (CHEBI:35703) (S)-nicotine (CHEBI:17688) is a 3-(1-methylpyrrolidin-2-yl)pyridine (CHEBI:138000) (S)-nicotine (CHEBI:17688) is conjugate base of (S)-nicotinium(1+) (CHEBI:59806) (S)-nicotine (CHEBI:17688) is enantiomer of (R)-nicotine (CHEBI:39162)

Incoming	(S)-6-hydroxynicotine (CHEBI:17532) has functional parent (S)-nicotine (CHEBI:17688) (S)-nicotine 1-N-oxide (CHEBI:132572) has functional parent (S)-nicotine (CHEBI:17688) (S)-nicotine N^1'-oxide (CHEBI:142659) has functional parent (S)-nicotine (CHEBI:17688) (S)-nicotinium N-α-D-glucosiduronate (CHEBI:63860) has functional parent (S)-nicotine (CHEBI:17688) nicotine (CHEBI:18723) has part (S)-nicotine (CHEBI:17688) (S)-nicotinium(1+) (CHEBI:59806) is conjugate acid of (S)-nicotine (CHEBI:17688) (R)-nicotine (CHEBI:39162) is enantiomer of (S)-nicotine (CHEBI:17688)

IUPAC Name

3-[(2S)-1-methylpyrrolidin-2-yl]pyridine

Synonyms	Sources
(−)-nicotine	ChemIDplus
(-)-3-(1-Methyl-2-pyrrolidyl)pyridine	HMDB
(-)-3-(N-Methylpyrrolidino)pyridine	HMDB
(R)-3-(1-Methyl-2-pyrrolidinyl)pyridine	HMDB
(S)-(−)-nicotine	NIST Chemistry WebBook
(S)-3-(1-methylpyrrolidin-2-yl)pyridine	KEGG COMPOUND
(S)-3-(N-methylpyrrolidin-2-yl)pyridine	IUBMB
(S)-Nicotine	KEGG COMPOUND
(S)-nicotine	ChemIDplus
1-Methyl-2-(3-pyridyl)pyrrolidine	HMDB
3-(1-Methyl-2-pyrollidinyl)pyridine	HMDB
3-(1-Methylpyrrolidin-2-yl)pyridine	HMDB
3-(2-(N-methylpyrrolidinyl))pyridine	NIST Chemistry WebBook
3-(N-methylpyrollidino)pyridine	NIST Chemistry WebBook
L(−)-nicotine	IUBMB
L-3-(1-Methyl-2-pyrrolidyl)pyridine	HMDB
L-Nicotine	HMDB
Nicotine	KEGG COMPOUND
Nicotine	HMDB

Manual Xrefs	Databases
1920	DrugCentral
485	BPDB
C00002057	KNApSAcK
C00745	KEGG COMPOUND
D03365	KEGG DRUG
DB00184	DrugBank
HMDB0001934	HMDB
LSM-2093	LINCS
NCT	PDBeChem
Nicotine	Wikipedia
NICOTINE	MetaCyc
View more database links

Registry Numbers	Types	Sources
3604351	Beilstein Registry Number	Beilstein
54-11-5	CAS Registry Number	KEGG COMPOUND
54-11-5	CAS Registry Number	ChemIDplus
54-11-5	CAS Registry Number	NIST Chemistry WebBook
82109	Reaxys Registry Number	Reaxys

Citations	Types	Sources
11209966	PubMed citation	Europe PMC
11322615	PubMed citation	Europe PMC
11406005	PubMed citation	Europe PMC
11719700	PubMed citation	Europe PMC
11768184	PubMed citation	Europe PMC
11821649	PubMed citation	Europe PMC
11851194	PubMed citation	Europe PMC
12575980	PubMed citation	Europe PMC
12692774	PubMed citation	Europe PMC
12769614	PubMed citation	Europe PMC
12850578	PubMed citation	Europe PMC
12971663	PubMed citation	Europe PMC
13590907	PubMed citation	Europe PMC
14674846	PubMed citation	Europe PMC
14761239	PubMed citation	Europe PMC
14975706	PubMed citation	Europe PMC
15019421	PubMed citation	Europe PMC
15027713	PubMed citation	Europe PMC
15251917	PubMed citation	Europe PMC
15276225	PubMed citation	Europe PMC
15380834	PubMed citation	Europe PMC
15502843	PubMed citation	Europe PMC
15527885	PubMed citation	Europe PMC
15707677	PubMed citation	Europe PMC
15734728	PubMed citation	Europe PMC
15826609	PubMed citation	Europe PMC
15894687	PubMed citation	Europe PMC
15902919	PubMed citation	Europe PMC
15960296	PubMed citation	Europe PMC
15963341	PubMed citation	Europe PMC
16059663	PubMed citation	Europe PMC
16212709	PubMed citation	Europe PMC
16333621	PubMed citation	Europe PMC
16370520	PubMed citation	Europe PMC
16496293	PubMed citation	Europe PMC
17023324	PubMed citation	Europe PMC
17206646	PubMed citation	Europe PMC
17292347	PubMed citation	Europe PMC
17350101	PubMed citation	Europe PMC
17498763	PubMed citation	Europe PMC
17504235	PubMed citation	Europe PMC
17525204	PubMed citation	Europe PMC
17560039	PubMed citation	Europe PMC
17683794	PubMed citation	Europe PMC
18380035	PubMed citation	Europe PMC
18383130	PubMed citation	Europe PMC
18490768	PubMed citation	Europe PMC
18683238	PubMed citation	Europe PMC
18685152	PubMed citation	Europe PMC
18805442	PubMed citation	Europe PMC
18922921	PubMed citation	Europe PMC
19100291	PubMed citation	Europe PMC
19100331	PubMed citation	Europe PMC
19287496	PubMed citation	Europe PMC
19389046	PubMed citation	Europe PMC
19448649	PubMed citation	Europe PMC
19465085	PubMed citation	Europe PMC
19850423	PubMed citation	Europe PMC
19954906	PubMed citation	Europe PMC
21521420	PubMed citation	Europe PMC
21636612	PubMed citation	Europe PMC
21822688	PubMed citation	Europe PMC
21945235	PubMed citation	Europe PMC
21947355	PubMed citation	Europe PMC
22030716	PubMed citation	Europe PMC
22129149	PubMed citation	Europe PMC
22218403	PubMed citation	Europe PMC
22265518	PubMed citation	Europe PMC
22331007	PubMed citation	Europe PMC
22377934	PubMed citation	Europe PMC
22459798	PubMed citation	Europe PMC
22529223	PubMed citation	Europe PMC
22530136	PubMed citation	Europe PMC
27951416	PubMed citation	Europe PMC
28187919	PubMed citation	Europe PMC
28391535	PubMed citation	Europe PMC
28574230	PubMed citation	Europe PMC
28641297	PubMed citation	Europe PMC
28678400	PubMed citation	Europe PMC
28683421	PubMed citation	Europe PMC
28686840	PubMed citation	Europe PMC
28698187	PubMed citation	Europe PMC
28700952	PubMed citation	Europe PMC
28704277	PubMed citation	Europe PMC
28710519	PubMed citation	Europe PMC
28711472	PubMed citation	Europe PMC
28714396	PubMed citation	Europe PMC
28718768	PubMed citation	Europe PMC
28718828	PubMed citation	Europe PMC
28726253	PubMed citation	Europe PMC
28735272	PubMed citation	Europe PMC

Last Modified

13 February 2023

CHEBI:17688 - (S)-nicotine

ChEBI is part of the ELIXIR infrastructure